1606 Corporation (PK) (CBDW) News

Same lies they used for Enzolytics

The global AI market, valued at $428 billion in 2022, is anticipated to reach $2.25 trillion by 2030, with a compound annual growth rate (CAGR) ranging from 33.2% to 38.1%. The sector is expected to employ 97 million individuals by 2025, reflecting its expansive and significant impact. This potential growth presents a compelling opportunity for investors and industry professionals interested in the AI sector.

$CBDW HUGE BUYING EOD CLOSED UP 38.00%. By protecting its proprietary technologies, CBDW can maintain a competitive edge, ensuring that its solutions remain unique and are not easily replicated by competitors. https://cbdw.ai/1606-corporation-cbdw-harnessing-competitive-advantage-through-expertise-industry-focus-and-intellectual-property/

Good Morning $CBDW

Fantastic Close!!!!!!!
Within the last 5 minutes of trading, it swung from being even to down all day and then wound up closing up 38.46%. Good thing someone stepped in the last 5 minutes and purchased 20,000 shares. By my calculations if all 20,00 shares were purchased at $0.018 per share that would be a total of $360.00 (plus any broker fees). Two press releases couldn't lift the share price all day, and someone had to step up at the end of the day to "paint the tape". This isn't looking good here.

Amazing Day Here! $CBDW $$ +38%

$CBDW Information on the Exclusive Live Investor Webinar and Q&A Session. Since it seems the board is just reposting old information; I thought this might be appropriate.

Join 1606 Corp.'s Exclusive Live Investor Webinar and Q&A Session on October 10th
SEATTLE, WA / ACCESSWIRE / October 7, 2024 /1606 Corp. (OTC PINK:CBDW) (the "Company," "1606," or "CBDW"), a leader in innovative AI chatbot solutions, is pleased to invite investors to a webinar on October 10, 2024, at 4:15 p.m. ET.

The exclusive event, hosted by RedChip Companies, will feature CBDW's CEO, Austen Lambrecht, who will share insight into the Company's innovative product portfolio and near-term expansion plans.
https://www.otcmarkets.com/stock/CBDW/news/story?e&id=3004658

AI scam

$CBDW Information on the Adnexus and Sanctum merger and 1606 Corps' role in the future of this merger. Adnexus Biotech and Sanctum Merge for Breakthrough HIV Treatment
#DrugDiscovery #HealthcareTech #Biotechnology #AIinBiotech https://finance.yahoo.com/news/1606-corp-target-strategic-investment-130000778.html

Stephen Popp / Gaurav Chandra / Tom Nelson scam 

Don't forget the fine print - Forward looking statement:

This press release includes forward-looking statements under federal securities laws, including projections and expectations regarding business developments, operations, and market conditions. These statements are identified by terms such as "should," "may," "intends," "anticipates," and others. While based on reasonable assumptions, results may differ due to various risks and uncertainties. Please review cautionary statements and disclosures in our filings with the SEC. The Company does not undertake any obligation to update forward-looking statements except as required by law.

$CBDW signed a Letter of Intent (LOI) with Adnexus Biotechnologies, a leading firm in AI and biotechnology solutions. This potential strategic investment underscores our commitment to expanding our technological footprint and enhancing our capabilities in the rapidly evolving field of AI. We believe the integration of Adnexus's cutting-edge AI research and development expertise would significantly bolster our portfolio, bringing advanced solutions to the intersection of artificial intelligence and healthcare and biotech.

$CBDW Austen Lambrecht, CEO of 1606 Corp., commented, "This has been a transformative quarter for 1606 Corp. With the successful filing of our third consecutive Quarterly Report, we continue to demonstrate our commitment to transparency and regulatory compliance. A key milestone for Q3 was the signing of our Letter of Intent with Adnexus Biotechnologies, which opens exciting new opportunities in the AI sector." Lambrechht continued, "We're building a strong foundation for long-term growth by expanding our technological capabilities and forging strategic partnerships. I'm incredibly proud of our team's progress and look forward to further advancing our mission of innovation and excellence in the months ahead."

Where's "good morning" girl?

https://x.com/CBDWInc/status/1858890908512456779

Today’s PR provided nothing new, just another tactic to raise the stock price #fail

This press release includes forward-looking statements under federal securities laws, including projections and expectations regarding business developments, operations, and market conditions. These statements are identified by terms such as "should," "may," "intends," "anticipates," and others. While based on reasonable assumptions, results may differ due to various risks and uncertainties. Please review cautionary statements and disclosures in our filings with the SEC. The Company does not undertake any obligation to update forward-looking statements except as required by law.

"This has been a transformative quarter for 1606 Corp. With the successful filing of our third consecutive Quarterly Report, we continue to demonstrate our commitment to transparency and regulatory compliance. A key milestone for Q3 was the signing of our Letter of Intent with Adnexus Biotechnologies, which opens exciting new opportunities in the AI sector." Lambrechht continued, "We're building a strong foundation for long-term growth by expanding our technological capabilities and forging strategic partnerships. I'm incredibly proud of our team's progress and look forward to further advancing our mission of innovation and excellence in the months ahead."

$CBDW News : 1606 Corp. AI Chatbots Innovations, Highlights Adnexus LOI, and Quarterly Reporting Update After Q3 Filling https://finance.yahoo.com/news/1606-corp-ai-chatbots-innovations-130000882.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr…

Looking ahead, 1606 Corp's focus will be on:

Closing Strategic Investment with Adnexus: We will be focused on closing the investment in Adnexus Biotechnologies.

Expanding AI Chatbot Solutions: We will continue to enhance our AI capabilities, with plans to launch additional AI-powered chatbot solutions that offer businesses even more advanced tools for automation, customer service, and engagement.

Growing Market Presence: Through the partnership with Adnexus, we aim to expand our reach into new verticals, such as healthcare, finance, and telecommunications, where AI chatbots are rapidly becoming essential for operational efficiency.

Increased Revenue from AI Chatbots: As AI solutions like Chat IR gain traction, we expect to see a rise in demand for our products, which we believe will contribute to revenue growth in the next quarter.

$CBDW NEWS: 1606 Corp. AI Chatbots Innovations, Highlights Adnexus LOI, and Quarterly Reporting Update After Q3 Filling
1606 Corp.
Tue, November 19, 2024 at 8:00 AM EST

In This Article: CBDW

SEATTLE, WA / ACCESSWIRE / November 19, 2024 / 1606 Corp. (OTC PINK:CBDW) (the "Company," or "1606") has made strong progress in the latest quarter, positioning itself as a key player in the growing AI chatbot market. The Company has focused on expanding its product offerings, forging strategic partnerships, and investing in innovative AI technology that enhances user interactions across industries. A key milestone for the Q3 includes strategic partnerships with Adnexus, marking a significant leap in the Company's AI-driven solutions.

Key Developments:

Quarterly SEC reporting:

We are excited to announce that we have filed our 10-Q for the quarter ended September 30, 2024. This filing reflects our commitment to transparency and regulatory compliance, providing investors and shareholders with detailed insights into our financial performance and operational activities. We are proud that we have been able to stay current with all fillings since our inception three years ago.

Expansion of Market Reach:
Throughout the quarter, we made substantial efforts to increase our market reach into the rapidly growing demand for AI-driven customer service and automation tools. We are committed to exploring new opportunities for expansion, particularly in sectors such as e-commerce, finance, healthcare, and telecommunications, where AI-powered chatbots are increasingly in demand. We have already created two chatbots that can be tested at cbdw.ai

Ongoing AI Innovation and Product Development:
Innovation remains at the core of our strategy, with a continuous focus on improving our AI chatbot capabilities. By integrating more advanced machine learning models and NLP techniques, we aim to provide highly personalized, human-like interactions for businesses and consumers alike.

Strategic Partnership with Adnexus Biotechnologies:
We signed a Letter of Intent (LOI) with Adnexus Biotechnologies, a leading firm in AI and biotechnology solutions. This potential strategic investment underscores our commitment to expanding our technological footprint and enhancing our capabilities in the rapidly evolving field of AI. We believe the integration of Adnexus's cutting-edge AI research and development expertise would significantly bolster our portfolio, bringing advanced solutions to the intersection of artificial intelligence and healthcare and biotech.

CEO Statement

Austen Lambrecht, CEO of 1606 Corp., commented, "This has been a transformative quarter for 1606 Corp. With the successful filing of our third consecutive Quarterly Report, we continue to demonstrate our commitment to transparency and regulatory compliance. A key milestone for Q3 was the signing of our Letter of Intent with Adnexus Biotechnologies, which opens exciting new opportunities in the AI sector." Lambrechht continued, "We're building a strong foundation for long-term growth by expanding our technological capabilities and forging strategic partnerships. I'm incredibly proud of our team's progress and look forward to further advancing our mission of innovation and excellence in the months ahead."

Outlook for the Next Quarter:

Looking ahead, 1606 Corp's focus will be on:

Closing Strategic Investment with Adnexus: We will be focused on closing the investment in Adnexus Biotechnologies.

Expanding AI Chatbot Solutions: We will continue to enhance our AI capabilities, with plans to launch additional AI-powered chatbot solutions that offer businesses even more advanced tools for automation, customer service, and engagement.

Growing Market Presence: Through the partnership with Adnexus, we aim to expand our reach into new verticals, such as healthcare, finance, and telecommunications, where AI chatbots are rapidly becoming essential for operational efficiency.

Increased Revenue from AI Chatbots: As AI solutions like Chat IR gain traction, we expect to see a rise in demand for our products, which we believe will contribute to revenue growth in the next quarter.

About 1606 Corp.

1606 Corp. stands at the forefront of technological innovation, particularly in AI Chatbots. Our mission is to revolutionize customer service, addressing the most significant challenges faced by consumers in the digital marketplace. We are dedicated to transforming the IR industry through cutting-edge AI centric solutions, ensuring a seamless and efficient customer experience.

As a visionary enterprise, 1606 Corp. equips businesses with the advanced tools they need to excel in the competitive digital landscape. Our commitment to innovation and quality positions us as a leader in the field, driving the industry forward and setting new benchmarks for success and customer satisfaction.

For more information, please visit cbdw.ai.

Industry Information

The global AI market, valued at $428 billion in 2022, is anticipated to reach $2.25 trillion by 2030, with a compound annual growth rate (CAGR) ranging from 33.2% to 38.1%. The sector is expected to employ 97 million individuals by 2025, reflecting its expansive and significant impact. This potential growth presents a compelling opportunity for investors and industry professionals interested in the AI sector.

Forward-Looking Statements

This press release includes forward-looking statements under federal securities laws, including projections and expectations regarding business developments, operations, and market conditions. These statements are identified by terms such as "should," "may," "intends," "anticipates," and others. While based on reasonable assumptions, results may differ due to various risks and uncertainties. Please review cautionary statements and disclosures in our filings with the SEC. The Company does not undertake any obligation to update forward-looking statements except as required by law.

Contact Information

Austen Lambrecht
CEO
austen@1606corp.com

SOURCE: 1606 Corp
View the original press release on accesswire.com

Breakthrough HIV and SARS-CoV-2 Treatments
https://www.accesswire.com/941303/1606-corp-target-for-strategic-investment-adnexus-biotechnologies-merges-with-sanctum-therapeutics-to-obtain-breakthrough-hiv-and-sars-cov-2-treatments

Austen Lambrecht, CEO of 1606 Corp., commented, "The merger between Adnexus Biotechnologies and Sanctum Therapeutics marks a pivotal moment in the fight against HIV and other infectious diseases. By combining Adnexus's cutting-edge AI-driven drug discovery platform with Sanctum's breakthrough therapies, they are not only advancing the development of life-saving treatments but also driving forward our mission to leverage technological innovation for the betterment of global healthcare. Lambrecht continued, "This strategic partnership underscores our commitment to supporting transformative biotech advancements, and we are excited to play a role in helping bring these therapies to market for those who need them most."

 I guess this post needs to be updated

Where's our happy pumping?Good morning to ya fella

The number of Outstand Shares has increased again. It is now at 112,251,332
https://www.otcmarkets.com/stock/CBDW/security

$CBDW Target for Strategic Investment Adnexus Biotechnologies Merges With Sanctum Therapeutics to Obtain Breakthrough HIV and SARS-CoV-2 Treatments
https://www.accesswire.com/941303/1606-corp-target-for-strategic-investment-adnexus-biotechnologies-merges-with-sanctum-therapeutics-to-obtain-breakthrough-hiv-and-sars-cov-2-treatments

L2 is thin to .03 $CBDW

Fantastic news! $CBDW
I gave ya a follow , hit me back. Cheers

$CBDW Check out this article about the connection between 1606 Corp and Adnexus #biotech https://allcapresearch.com/f/adnexus-biotech-and-sanctum-merge-for-breakthrough-hiv-treatment

Good Morning $CBDW

$CBDW New Article : Adnexus Biotech and Sanctum Merge for Breakthrough HIV Treatment

Read more here CBDW Update

Monster close friday..........

$CBDW Form 10-Q filed for Period Ending September 30, 2024! https://ih.advfn.com/p.php?pid=nmona&article=94925707

Wtf are you talking about lately

Hopefully for the "investors" here the future is brighter than the pumpers.

The future is almost as bright as all the pumpers here

Fantastic close here. Hopefully all of you have read the 10-Q that was released. The future is bright here?

$CBDW +39% on 10-Q release.

$CBDW 10-Q is out ----> https://www.otcmarkets.com/filing/html?id=17980488&guid=jsY-kHcQEEJpJth

SONIC BOOM >>>> $CBDW

Weeeeeeeeee $CBDW

$CBDW Founder Greg Lambrecht on LinkedIn -"The role of AI is advancing rapidly, promising transformative impacts on efficiency, accuracy, and customer experience." https://www.linkedin.com/posts/greg-lambrecht_artificialintelligence-futureofwork-automation-activity-7263219691551105024-QmKl?utm_source=share&utm_medium=member_desktophttps://cbdw.ai/ #ArtificialIntelligence #FutureOfWork #Automation #CustomerService #EthicalAI #FinancialServices #Innovation #1606Corp #CBDWAI

Yes, it's Tom Nelson the dirtbag.  

Good Morning $CBDW

I have not seen something pumped so hard, do so poorly.

This is a hilariously sad pump.  Trooperstocks post about ending the week strong (that is halrious in itself) then goes and does all the thumbs up, hearts and whatever likes on their own post to draw attention. Is this a paid promoter?

$CBDW Looking to rebound and close the week strong! As technology reshapes the investor relations (IR) industry, 1606 Corp is positioning itself at the forefront with a suite of AI-driven conversational chatbots designed to streamline and enhance investor relations https://allcapresearch.com/f/1606-corp%E2%80%99s-strategy-to-lead-in-ai-driven-investor-relations

When SAGA was going to purchase the IP from ENZC it was for an estimated $450 million. The buyout price was then reduced when the BGEN (now called Adnexus) part was removed from the deal. That should give a rough idea of what someone thought this was worth. I'm not clear on where the funds are coming from. It does not appear that 1606 Corp has any capital (SAGA did not appear to have any capital as well) from the filings that they post, so I do not know what Adnexus (formerly ENZC subsidiary BGEN) is worth.

5% of what…. No $$$ amount, therefore no clear indication of what they think Adnexus is worth